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Non-occlusive Prosthetic Thrombosis on
Transoesophageal Echocardiography After
Mitral Surgery: Evolution with Medical Treatment
Cholesterol
(mg/dLI
Thrombus Volume (fJ.m31fJ.m2 of media)
Control DMHD/NO (001 fJ.M) NTP (0.1 fJ.M)
VASCULAR/CORONARY DISEASE/THROMBOSIS - BASIC
Sanjay Kaul, Tasneem Z. Naqvi, Michael C. Fishbein, Bojan Cercek, James
S. Forrester, Mia D. Molloy, Juan J. Badimon, Thomas C. Hutsell 1, Prediman
K. Shah. Cedars-5inai Medical Center/UCLA School of Medicine, Los Angeles, CA;
1 Comedicus Incorporated, Minneapolis, MN
63 ± 15 9 ± 5*Y 42 ± 21
86±1415±5*Y 64±25
Oxidized LDL Stimulates Mitogen-activated
Protein Klnases in Smooth Muscle Cells and
Macrophages
33 ± 11
405 ± 155
N In ~ 5)
He In = 6)
Mean arterial pressure fell by 3% and 15% after DMHD/NO and NTP infu-
sion, respectively. NTP produced minimal antithrombotic effect at a concen-
tration of 0.01 fJ.M. Infusion of saline had no effect on thrombus formation
in either N or He rabbits.
Conclusion: DMHD/NO, a novel NO donor, produces profound inhibition
of arterial thrombosis in N as well as HC rabbits, without significant systemic
hemodynamic effects. In contrast, antithrombotic effects of NTp, even at a
10-fold higher dose that produces pronounced systemic hypotension, are
modest. Thus, inhibition of thrombosis by a novel nitric oxide donor may be
an effective strategy for treatment of arterial injury-induced thrombosis.
Values are mean ± SEM, *p < 0.01 vs control, Y p < 0.01 vs NTP
Masatoshi Kusuhara, Shari Wang, Alan Chait, Bradford Berk. University of
Washington, Seattle, WA
Cellular proliferation and lipid infiltration in vessels are important events in
atherogenesis. Recent data suggest an important role for LDL and oxidized
LDL (ox-LDLI in the initiation and maintenance of atherosclerosis. The mech-
anisms by which LDL and ox-LDL affect cellular proliferation are not clear.
A critical signal transduction event universally stimulated by growth factors
is activation of mitogen-activated protein kinases IMAPK). We therefore ex-
amined the effect of LDL and ox-LDL on MAPK activity in cultured smooth
muscle cells (SMC) and macrophages by using an in-gel-kinase assay with
myelin basic protein as substrate. LDL and ox-LDL stimulated MAPK in a
time- and dose-dependent manner in baboon, monkey, and rat SMC, but not
in bovine endothelial cells. Ox-LDL also stimulated MAPK in macrophages
but the effect was only present after freshly isolated cell as were cultured
for 7 days. The maximal response to ox-LDL (340% increase over control)
occurred at 50 fJ.g/ml at 5 min in rat SMC, with half-maximal response at
10 fJ.g/ml. Ox-LDL stimulated MAPK 2-fold more than native LDL. Stimula-
tion of MAPK was mediated by protein kinase C (PKC) as phorbol ester pre-
treatment for 24 hr blocked MAPK activation. The active moiety was a lipid,
based on the ability to extract the MAPK activating material from ox-LDL us-
ing chloroform, These data show that LDL stimulates MAPK in SMC via a
PKC-dependent pathway, that oxidation of LDL potentiates the effect, and
that a lipid is involved. These data establish a new growth related signal,
MAPK activation, that is more powerfUlly stimulated by ox-LDL than LDL in
SMC. In addition, there appears to be dynamic regulation of the cellular re-
sponse to ox-LDL based on the differences between freshly isolated and cul-
tured macrophages. This knowledge should be useful in understanding the
mechanisms by which ox-LDL promotes SMC proliferation and macrophage
dysfunction in atherogenesis.
Computer Aided Instruction: Session I
Stephen G. Morris 1, Aman S. Coonar, Jill M. Szuscikiewicz 1, Jonathan
H. Goldman, William J. McKenna. 1Departments of Cardiological Sciences and
Computing & Information, St George s Hospital Medical School, London, SWI7, Ore, UK
Computer Assisted Instruction (CAl) is a novel method of medical education.
The teaching of cardiology may benefit from the use of text, sound, images,
animation, video as well as hypertext in the true hypermedia environment
provided by CAL
Our pilot has been developed for use by undergraduate and postgraduate
students. The knowledge base and analytical skills are given in the introduc-
tion to each section, fOllowing which a range of clinical scenarios, laboratory
values, ECG, X-Ray, echocardiographic, C1 and MRI cases are presented for
interpretation. Progress is assessed by multiple choice questions, case and
data interpretations, and the ability to employ established management al-
gorithms. A sophisticated series of 'What If'® challenges are built in, allowing
the student to alter the complicating factors and degree of patient compro-
mise.
By use of multiple cross-references, students may determine their unique
path through the material. The software includes a feature, Talkback'® en-
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Profound Inhibition of Arterial Thrombosis by a
Novel Nitric Oxide Donor
Plaque Constituents in Patients with Stable and
Unstable Angina: An Atherectomy Study
Jessica M. Mann, Juan C. Kaski, S. Arie 1, Wagner I. Pereira 1, Fulvia Pileggi 1,
Michael J. Davies. St George's Hospital Medical School, London, UK; llNCOR, Sao
Paulo, Brazil
Bernard lung, Bertrand Cormier, Jean Marc Porte, Eric Dadez, Charles Starkman,
Jean Acar, Alec Vahanian. Cardiology Department, Tenon Hospital, Pans. France
Transoesophageal echocardiography (TEE) after mitral valve replacement
(MVR) with a mechanical prosthesis may reveal non-occlusive thrombi in the
prosthesis in asymptomatic patients (pts). The clinical implications of these
thrombi remain however debated.
Between 1988 and 1993, 183 consecutive pts underwent MVR with a
bileaflet prosthesis (Saint-Jude 134, Sorin 22, Carbomedics 20, Duromedics
7). Their mean age was 56 ± 13 yrs. EarlyTEE was performed 15 ± 6 days af-
ter surgery and revealed thrombi in the prosthesis in 22 pts (12%). No pt had
symptoms. Two pts were re-operated on because of large, mobile thrombi.
In the 20 other cases, Doppler did not show any obstruction in the prosthe-
sis (mean gradient 5 ± 2 mmHg [3-9JI, and the motion of both leaflets was
normal on TEE and fluoroscopy.
A total of 27 thrombi was visualized in these 20 pts. Maximal size of the
thrombi was <5 mm in 9 cases, 5 to 10 mm in 12 cases, and> 10 mm in
6 cases; 70% of these thrombi were mobile. These 20 pts were treated
by carefully controlled anticoagulation with heparin (serum levels 0.2 to 0.4
U/mL) andlor vitamin K antagonists (INR 3 to 4.5). No pt received throm-
bolytic therapy. Repeat TEE in these 20 pts showed that thrombi disappeared
after one month in 15 cases (75%), and in all the cases after a mean period of
58 ± 99 days [7-210]. Only one pt experienced a transient ischaemic attack
without sequelae.
In conclusion (1) Non-occlusive thrombi in the prosthesis are frequently
observed on early TEE after MVR. (2) They seldom cause embolic events. (3)
They disappear with anticoagulant therapy, in the majority of cases within
one month.
Directional coronary atherectomy IDCAI is used both in patients with sta-
ble and unstable angina to relieve the coronary obstruction. Although the
tissue retrieved during DCA has the disadvantage of being only a random
portion of the atherosclerotic plaque, it offers a unique possibility to corre-
late the histological findings with the clinical picture. We studied 48 patients
Ipts) (mean age 57 ± 10 years), 34 with stable angina and 14 with unsta-
ble angina, who underwent DCA. Nine of the 34 pts with stable angina had
thrombus in the DCA specimen (26%), and 8 of the 14 (57%) unstable pts
(p NS). Cholesterol clefts and macrophages (CCM) were identified in 13/48
pts (27%), and were significantly associated with the presence of thrombus
(p < 0.00006). A pattern of storiform smooth muscle cell proliferation in a
connective stroma (rapid progression) was identified in 27 pts (56%), being
more frequent in those patients with thrombus (12/17, 71 %1, than in those
without (15/31,48% p NSI. A small subgroup of pts with stable angina who
had episodes of pain at rest, all had the rapid progression pattern (11111,
100%). This pattern reflects healing of a previous plaque event, is identical
to that observed post-angioplasty and can result in high degree stenosis
The strong statistical association between the presence of thrombus and
that of cholesterol and macrophages confirms - in live patients - previous
autopsy data regarding the components of the plaque "at risk" for plaque
disruption,
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We compared antithrombotic effects of a novel short-lived (half-life
of 1 minute) nitric oxide (NO) donor - NO adduct of N,N'-dimethyl-
hexanediamine (DMHD/NO) and nitroprusside (NTP) in an ex vivo rabbit
carotid-jugular arterio-venous shunt thrombosis model. Strips of porcine aor-
tic media (simulating deep arterial injury) were placed in a Badimon perfusion
chamber and exposed to flowing arterial blood from normal (N) and hyperc-
holesterolemic (He) rabbits at a shear rate of 1700/s (typical of mild coronary
stenosis) for 10 minutes. Thrombus volume was quantified in control and
treated strips by morphometry of histological sections, Treatment included
DMHD/NO, NTP. and phosphate buffered saline as control.
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Predictors of Restenosis
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1701-21 The Final % Cross-sectional Narrowing (Residual
Plaque Burden) is the Strongest Intravascular
Ultrasound Predictor of Angiographic Restenosis
Gary S. Mintz, Ya Chien Chuang, Jeffrey J. Popma, Augusto D. Pichard, Kenneth
M. Kent, Lowell F. Satler, Theresa A. Bucher, Jennifer Griffin, Martin B. Leon.
Washington Hospital Center. Washington, DC
We analyzed clinical, intravascular ultrasound (IVUSI, and angiographic pre-
dictors of restenosis (follow-up quantitative angiographic % diameter steno-
sis >50) in 384 lesions (133 LAD, 42 LCX, 121 RCA. 88 SVG) in 322 pts
(259 males, ages 59 ± 11 yrs). Transcatheter devices were 56 PTCA; 126
directional. 70 rotational, and 3 extraction atherectomy; 56 stents; and 73
excimer laser angioplasty. Univariate IVUS parameters tested included refer-
ence site and target lesion pre- and post-intervention external elastic mem-
brane (EEM), lumen, and plaque areas; % cross-sectional narrowing (%CSN
= plaque/EEM area); and lesion morphology (eccentricity, plaque composi-
tion, calcium, and dissections). Using multivariate analyses, the most consis-
tent predictor of follow-up angiographic findings was the IVUS final % CSN.
Using logistic regression analysis, the final %CSN predicted restenosis (odds
ration 2.09; 95% confidence interval = 1.50-2.92, P < 0.001, Figure); using
linear regression analysis, %CSN predicted both the follow-up angiographic
% diameter stenosis (r = 0.371, P < 0.001) and minimum lumen diameter (r
= 0.396, P < 0.001). In addition, various reference segment measurements
(eg., angiographic lumen diameter or IVUS EEM or lumen area or %CSN)
were included in some of the multivariable models; but no one measure
of reference vessel size or disease consistently predicted follow-up results.
Importantly, the following did not predict restenosis: (1) lesion morphology
and 12) mechanisms of lumen enlargement (increase in EEM or decrease in
plaque). We Conclude: The final IVUS %CSN was a more powerful predic-
tor of restenosis than clinical or angiographic variables. Either an increase in
EEM (vessel expansion) or a decrease in plaque (tissue removal) will reduce
the final % CSN. Thus, it is the magnitude, not the mechanism, of successful
transcatheter therapy that is related to freedom from restenosis.
with larger vessel size, which is an independent determinant of less luminal
loss (p < 0.0001), longer lesions were found to be independently associated
with greater late loss and a smaller luminal diameter at follow up. Dividing
the lesion population in 9 equal groups (nonilesl, the shortest lesions (mean
2.98 ± 0.66 mm) had a loss of 0.25 ± 0.49 mm and a % stenosis at follow
up of 43 ± 20% while the longest (mean 10.86 ± 1.70 mm) had a loss of
0.37 ± 0.55 mm and a % stenosis at follow up of 50 ± 19% (p < 0.0001).
Despite these angiographic findings of poorer late angiographic results, the
frequency of major adverse cardiac events, total occlusion or binary resteno-
sis (diameter stenosis ~50%) at follow up, did not vary with lesion length.
Conclusion: Although longer coronary lesions are independently associ-
ated with less favourable late angiographic results after successful balloon
angioplasty, this does not appear to translate into poorer late clinical out-
come. The long term clinical implications of angiographically quantified pre-
interventionallesion length remain to be determined.
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1701-31 Prediction of the Risk of Angiographic Restenosis by
Intracoronary Ultrasound Imaging After Coronary
Balloon Angioplasty
Ron J.G. Peters, PICTURE Study group (Post Intra Coronary Treatment Ultrasound
Result Evaluation). InterUniversity Cardiology Institute, Utrecht. The Netherlands
The aim of the PICTURE study is to relate arterial wall morphology on intra-
coronary ultrasound images (ICUS) after balloon angioplasty (SA) to the risk
of quantitative coronary angiographic (OCA) restenosis at 6 months. Of the
200 patients included, data are now complete in 133. With 112 (84%) repeat
angiograms and 8 patients with 2 lesions, 119 lesions were available for in-
terim analysis. A >50% diameter stenosis on OCA at 6 months was present
in 30.3%. On OCA after SA, mean minimal lumen diameter was 1.71 in the
Computer Modeling for Real-time Interactive
Demonstration of Reentry and Induction of
Tachycardia: A Teaching Tool
abling students to comment anonymously on the tutorial. Sy mapping the
student's path, and including their comments at each stage, focussed sup-
plementary tutorials can be provided.
The pilot is undergoing evaluation. Early data is positive for face validity,
and compares favourably against conventional methods of teaching such as
lectures. On completion the project will undergo a full evaluation process at
St George's Hospital Medical School, and elsewhere in the UK.
The CAl runs on a standard PC 486 as well as the Macintosh.
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David P. Foley, Rein Melkert, David Keane, Andonis G. Violaris, Patrick W. Serruys.
Thoraxcentre, Erasmus University, Rotterdam, Netherlands
The induction and termination of reentrant tachycardia are difficult to con-
ceive with electrograms only. An interactive computer model based on con-
duction and refractory time is constructed for real-time simulation of reentry.
Written in Microsoft C+ + v. 6.0, 2 pathways (Pl , P2) connected at both ends
(A, V) are created. There are 2 cells at each end and 7 cells in each pathway
(Figure). There is 1 simulated electrogram each for surface ECG, atrium, the
2 pathways, and ventricle. The cell "on" time (I). "off" time (0), and stimula-
tion threshold can be changed. The cells are in a "ready" state when they
are not "on" or "off", with different designated colors. The model can be
"paced" from the pacelsense cells with various coupling intervals (C). and
the cells will be sequentially turned "on" after I of the preceding cell, if they
are "ready". After I, the cells become "off" for the duration of 0 li.e. refractory
time) before returning to "ready". The simulated electrograms in the respec-
tive channels show the P (or A) and ORS (or V) waves corresponding to the
"on" state of the pacelsense cells. The "surface ECG" also shows T waves
during the "off" state of the Vend. The sum of I of the 7 cells determines
the pathway conduction time. I of the 2 pathways can also be determined
by an equation to simulate the properties of the atrioventricular node: I =
AHoc + D*exp(-CIr). I and C represent the A2H2 and A1A2 intervals respec-
tively, AHoo is the asymptotic cycle length approached as A, A2 increases,
and D and r are constants. AHoo , D, and r obtained from curve fitting can be
changed to simulate clinical cases. Decremental pacing or extrastimuli can
induce or terminate reentrant tachycardia of the computer, as seen from the
propagation of cell activation and the simulated electrograms. Conclusion:
It is feasible to create an interactive computer model for real-time simulation
of reentry based on the conduction and refractory time of 2 pathways. This
model can be a useful teaching tool for reentry.
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Hue-Teh Shih, Liew Shin Wu, Edith Shin Wu. University of Texas Medical School at
Houston, Houston. TX; Johnson Engineering Co., Houston, TX
The influence of target lesion length, measured by an automated edge de-
tection system (CAAS), on late angiographic and clinical outcome after suc-
cessful coronary balloon angioplasty (SA). was investigated among 3124 pa-
tients with 3513 non-occlusive native coronary lesions. Ouantitative angiog-
raphy was performed before and after SA and at 6 month follow up. Visu-
ally assessed post-SA diameter stenosis <50% was considered successful.
Late clinical outcome was considered as occurrence of or freedom from,
major adverse cardiac events ("MACE": death, myocardial infarction, coro-
nary artery bypass graft surgery, re-intervention). or target lesion reocclu-
sion at follow up angiography, within 6 months of SA. In univariate analysis,
longer lesions were associated with larger reference vessel diameter (p <
0.0001) and greater acute luminal gain (p < 0.01), but also greater late loss
(p < 0.001) and greater % stenosis at follow up (p < 0.0001). To determine
whether lesion length is an independent determinant of late loss or late lu-
minal diameter, multiple linear regression analysis was carried out. including
the influence of lesion location, vessel size, pre-procedural minimal luminal
diameter and procedural luminal gain. Although lesion length was associated
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